Skip to main content
. Author manuscript; available in PMC: 2014 Feb 15.
Published in final edited form as: Epilepsy Behav. 2013 Jan 8;26(3):427–439. doi: 10.1016/j.yebeh.2012.10.031

Table 2.

Effects of prenatal or early life exposure to phenobarbital in children and laboratory animals.

Phenobarbital Effects on offspring of maternal AED use
Effects on offspring of early postnatal use
Human Rodent Human Rodent
Somatic
  General body size Mixed results Decreased (*)
  Facial features Mixed results—cleft palate
  Limbs, skeleton
  Developmental milestones Delays on BMDI (*) Impaired righting reflexes
CNS
  General brain size Decreased head circumference Decreased weight Decreased weight
  Specific brain areas
    Cerebellum Decreased cell number Decreased cell number/apoptosis;
mismigration
    Hippocampus Decreased cell number Decreased cell number/apoptosis;
mismigration
  Sensory systems
  Motor systems Delayed neurological
development
Decreased muscle, delayed
swimming
Hyperactivity/reduced
reaction times
Hyperactivity
Cognitive functions
  IQ, BMDI score Decreased (*) Decreased
  Learning and memory Decreased (*) General impairments Transient, variable General impairments
Behavior
  Mood (depression) Fussiness, depression,
irritability
  Attention deficits Working memory impairments Impaired concentration Working memory impairments
and attention
  Autistic-like behavior Decreased play behavior
  Schizophrenia-like Impaired prepulse inhibition
  Anxiety Increased (*)

Somatic, cognitive and behavioral effects are shown for prenatal exposure (left) and early postnatal exposure (right). The table indicates common findings, and where variability is noted, it may be due to differences in the study parameters/methods, doses, or times of exposure.

*

indicates presence of conflicting reports in the literature. References are provided in the text.

Abbreviations: BMDI, Bayley Mental Developmental Index.